Nebenwirkungen · Evrenzo
Evrenzo 20 mg film-coated tablets Evrenzo 50 mg film-coated tablets Evrenzo 70 mg film-coated tablets Evrenzo 100 mg film-coated tablets Evrenzo 150 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 10
HOS-142697 · Präparat HOS-098854
Table 3. Adverse reactions MedDRA System organ class Frequency category Adverse reaction (SOC) Infections and infestations Common Sepsis Blood and lymphatic system Common Thrombocytopenia disorders Endocrine disorders Not known Secondary hypothyroidism Metabolism and nutrition Very common Hyperkalaemia disorders Psychiatric disorders Common Insomnia Nervous system disorders Common Seizures, headache Uncommon Cerebral infarction Vascular disorders Very common Hypertension, vascular access thrombosis (VAT)1 Common Deep vein thrombosis (DVT) Respiratory, thoracic, Uncommon Pulmonary embolism mediastinal disorders Gastrointestinal disorders Very common Nausea, diarrhoea
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-05-12T11:44:00Z · SHA-256 88f6c6d4aebd389bf222daad472d08af1f853b3fc663a716c6447c3c0cff2400 · Passage c0bdb0bff7f94b3b006a98988cd81ec7d27c534c268f424a36893ff701c6b2bf · Zeichen 1032–2247 im Abschnitt